---
title: Rubella virus seropositivity after infection or vaccination as a risk factor
  for multiple sclerosis
date: '2024-07-18'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39023088/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240718182022&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSIONS: To our knowledge, these are the first reported associations
  between early RV seropositivity and later MS development. This suggests a broadening
  of the virus hypothesis in MS aetiology, where molecular mimicry between rubella
  epitopes and human central nervous system molecules could be an attractive possible
  ...'
disable_comments: true
---
CONCLUSIONS: To our knowledge, these are the first reported associations between early RV seropositivity and later MS development. This suggests a broadening of the virus hypothesis in MS aetiology, where molecular mimicry between rubella epitopes and human central nervous system molecules could be an attractive possible ...